Your account is not claimed yet. You can sign up with ORCID to claim your account.

Amin Reza Nikpoor

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 9

Top Venues

Cell biology international

Phytotherapy research : PTR

Journal of cellular and molecular medicine

Epigenomics

Hormozgan University of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Hormozgan University of Medical Sciences

Iran

PHD :: Immunology

Publications

Shirin Beyranvand, Parivash Davoodian, Hesam Alizade, Hamed Gouklani, Azim Nejatizadeh, Ebrahim Eftekhar, Amin Reza Nikpoor
Study of frequency and inheritance model of ACE1 I/D and ACE2 rs2285666 polymorphisms in COVID-19 patients with varying severity of lung involvement and its effect on serum cytokines levels. Cell biology international (2022)
Shirin Beyranvand, Parivash Davoodian, Hesam Alizade, Hamed Gouklani, Azim Nejatizadeh, Ebrahim Eftekhar, Amin Reza Nikpoor
Study of frequency and inheritance model of ACE1 I/D and ACE2 rs2285666 polymorphisms in COVID-19 patients with varying severity of lung involvement and its effect on serum cytokines levels. Cell biology international 47 (4) (2022)
Shirin Beyranvand, Parivash Davoodian, Hesam Alizade, Hamed Gouklani, Azim Nejatizadeh, Ebrahim Eftekhar, Amin Reza Nikpoor
Study of frequency and inheritance model of ACE1 I/D and ACE2 rs2285666 polymorphisms in COVID-19 patients with varying severity of lung involvement and its effect on serum cytokines levels. Cell biology international 47 (4) (2022)
Elham Karimi, Hanieh Azari, Sirous Tahmasebi, Amin Reza Nikpoor, Ahmad Agha Negahi, Nima Sanadgol, Mohammad Shekari, Mousavi Pegah
LncRNA-miRNA network analysis across the Th17 cell line reveals biomarker potency of lncRNA NEAT1 and KCNQ1OT1 in multiple sclerosis. Journal of cellular and molecular medicine 26 (8) (2022)
Shirin Beyranvand, Parivash Davoodian, Hesam Alizade, Hamed Gouklani, Azim Nejatizadeh, Ebrahim Eftekhar, Amin Reza Nikpoor
Study of frequency and inheritance model of ACE1 I/D and ACE2 rs2285666 polymorphisms in COVID-19 patients with varying severity of lung involvement and its effect on serum cytokines levels. Cell biology international (2022)
Shirin Beyranvand, Parivash Davoodian, Hesam Alizade, Hamed Gouklani, Azim Nejatizadeh, Ebrahim Eftekhar, Amin Reza Nikpoor
Study of frequency and inheritance model of ACE1 I/D and ACE2 rs2285666 polymorphisms in COVID-19 patients with varying severity of lung involvement and its effect on serum cytokines levels. Cell biology international 47 (4) (2022)
Hanieh Azari, Elham Karimi, Mohammad Shekari, Sirous Tahmasebi, Amin Reza Nikpoor, Ahmad Agha Negahi, Nima Sanadgol, Mousavi Pegah
Construction of a lncRNA-miRNA-mRNA network to determine the key regulators of the Th1/Th2 imbalance in multiple sclerosis. Epigenomics 13 (22) (2021)
Mehdi Hassaniazad, Ebrahim Eftekhar, Behnaz Rahnama Inchehsablagh, Hossein Kamali, Abdolali Tousi, Mahmoud Reza Jaafari, Milad Rafat, Mohammad Fathalipour, Sara Nikoofal-Sahlabadi, Hamed Gouklani, Hesam Alizade, Amin Reza Nikpoor
A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients. Phytotherapy research : PTR 35 (11) (2021)
Mehdi Hassaniazad, Behnaz Rahnama Inchehsablagh, Hossein Kamali, Abdolali Tousi, Ebrahim Eftekhar, Mahmoud Reza Jaafari, Mohammad Fathalipour, Sara Nikoofal-Sahlabadi, Hamed Gouklani, Hesam Alizade, Amin Reza Nikpoor
The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: A structured summary of a study protocol for a randomised controlled trial. Trials 21 (1) (2020)

Amin Reza Nikpoor.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Amin Reza Nikpoor